Sri Lanka Active Devices IEC Electrical Safety and EMC Testing

1. Key takeaways

For active medical devices, Sri Lanka requires additional IEC electrical safety and electromagnetic compatibility (EMC) test reports. The attribute of being an active device is simultaneously one of the determinants of product classification and one of the exclusion conditions of the low-risk pathway. This means a single factual question — does the device draw power to perform its intended function — reaches into three separate parts of the regulatory logic at once. Answer it wrong at the start and the wrong classification follows, the wrong test plan follows, and the wrong pathway assessment follows. Because most active equipment also contains embedded software, the attribute typically brings a further evidence obligation with it under the software provisions of GL-034. Identifying the active attribute early, and deliberately, is therefore one of the highest-leverage decisions in the whole dossier preparation exercise, and it costs nothing but attention at the intake stage. For manufacturers with multi-country portfolios, the same determination usually feeds directly into the Sri Lankan submission, since the electrical safety and EMC campaigns performed for other markets can frequently be referenced or reused where their scope and standard versions align with what the reviewer expects.

• Active devices require IEC electrical safety and EMC test reports under GL-034, effective 2025-07-23.
• Classification determinants under GL-037, effective 2026-05-13, include intended use, degree of invasiveness, duration of contact, and whether the device is active.
• The low-risk pathway requires the product to be simultaneously non-sterile, non-active, and without measuring functions — so any active device is excluded by definition.
• General device classification follows the classification principles and rules of the European Union Medical Device Regulation.
• Special supplements under GL-034 include biological evaluation, clinical evaluation, and software verification and validation, applied as needed.

2. Legal basis

The electrical safety and EMC reporting requirement derives from GL-034, which took effect on 2025-07-23. The classification determinants, the low-risk pathway thresholds, and the classification reference for active devices derive from GL-037, which took effect on 2026-05-13. Special supplements apply as needed under GL-034.

3. Expert insights

Insight one: the active attribute has a triple impact. It affects (1) the product classification class, (2) the special test requirements (electrical safety plus EMC), and (3) eligibility for the low-risk pathway. One attribute touches three stages, and it must be determined accurately at the classification stage. A device that is wrongly recorded as non-active will not be asked for IEC and EMC reports at intake, but the omission will surface during technical assessment, by which time the test campaigns — which take real calendar time — will sit on the critical path. The determination itself is rarely difficult; the failures come from rushing the intake question or letting product variants differ without noticing.

Insight two: EMC and electrical safety come as a pair, not as alternatives. The wording of the rule is IEC electrical safety and electromagnetic compatibility reports, with the two items juxtaposed. Submitting only one constitutes a missing item. Manufacturers familiar with other markets sometimes assume that a single combined report suffices, or that EMC testing can be deferred; in Sri Lanka the pairing is explicit, and the reviewer will look for both documents. Scheduling the two campaigns together with the same laboratory is usually the most efficient arrangement, since the sample preparation and set-up overlap substantially, and any retest needed on one campaign can be combined with the other rather than queued separately.

Insight three: active and software usually appear together. Most active devices contain software, and GL-034 sets separate evidence requirements for software devices, so a software verification and validation report must be prepared in addition. The obligation applies regardless of whether the software is embedded in the device or runs alongside it as a standalone product, which is why the software determination belongs at intake rather than at the end of preparation. Devices whose software influences therapy delivery or diagnostic output carry correspondingly higher expectations on the depth of the verification and validation report, so the earlier the determination is made, the more realistically the report can be scoped.

One further caution on timing: test reports age. A report that was valid when the project was planned may approach its limit by the time the dossier reaches review, which is why the checklist in this article includes verifying the validity period and the standard versions of every test report before submission rather than after.

4. Practical recommendations

• GRZAN handles active-device projects by adding a separate line, software confirmation, outside the standard checklist: first determine whether the product contains software, then determine whether the software is standalone or a component of the device, and from this decide whether a software verification and validation report is needed.
• Without that line written into the checklist, the software evidence requirement is easily discovered only at the deficiency stage — after the submission clock has already started.
• Confirm the applicability and version of the standards used for the IEC and EMC campaigns, so the reports align with what the reviewer expects to see.
• Book electrical safety, EMC, and any software verification work in one coordinated schedule to avoid serial delays.

5. Verification checklist

• □ Confirmed whether the product is an active device
• □ IEC electrical safety test report obtained
• □ Electromagnetic compatibility (EMC) test report obtained
• □ Software-containing products attach a software verification and validation report
• □ Validity and applicable standard versions of the test reports verified

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Sri Lanka. Our team prepares dossiers to NMRA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com